Literature DB >> 17611264

The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.

Onanong Chivatakarn1, Shinjiro Kaneko, Zhigang He, Marc Tessier-Lavigne, Roman J Giger.   

Abstract

Neuronal Nogo-66 receptor 1 (NgR1) has been proposed to function as an obligatory coreceptor for the myelin-derived ligands Nogo-A, oligodendrocyte myelin glycoprotein (OMgp), and myelin-associated glycoprotein (MAG) to mediate neurite outgrowth inhibition by these ligands. To examine the contribution of neuronal NgR1 to outgrowth inhibition, we used two different strategies, genetic ablation of NgR1 through the germline and transient short hairpin RNA interference (shRNAi)-mediated knock-down. To monitor growth inhibition, two different paradigms were used, chronic presentation of substrate-bound inhibitor to measure neurite extension and acute application of soluble inhibitor to assay growth cone collapse. We find that regardless of the NgR1 genotype, membrane-bound MAG strongly inhibits neurite outgrowth of primary cerebellar, sensory, and cortical neurons. Similarly, substrate-bound OMgp strongly inhibits neurite outgrowth of NgR1 wild-type and mutant sensory neurons. Consistent with these results, shRNAi-mediated knock-down of neuronal NgR1 does not result in a substantial release of L-MAG (large MAG) inhibition. When applied acutely, however, MAG-Fc and OMgp-Fc induce a modest degree of growth cone collapse that is significantly attenuated in NgR1-null neurons compared with wild-type controls. Based on our findings and previous studies with Nogo-66, we propose that neuronal NgR1 has a circumscribed role in regulating cytoskeletal dynamics after acute exposure to soluble MAG, OMgp, or Nogo-66, but is not required for these ligands to mediate their growth-inhibitory properties in chronic outgrowth experiments. Our results thus provide unexpected evidence that the growth cone-collapsing activities and substrate growth-inhibitory activities of inhibitory ligands can be dissociated. We also conclude that chronic axon growth inhibition by myelin is mediated by NgR1-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611264      PMCID: PMC6794578          DOI: 10.1523/JNEUROSCI.1541-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins.

Authors:  William A Barton; Betty P Liu; Dorothea Tzvetkova; Philip D Jeffrey; Alyson E Fournier; Dinah Sah; Richard Cate; Stephen M Strittmatter; Dimitar B Nikolov
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

Review 2.  Regulating axon growth within the postnatal central nervous system.

Authors:  Fenghua Hu; Stephen M Strittmatter
Journal:  Semin Perinatol       Date:  2004-12       Impact factor: 3.300

3.  Response to correspondence: Kim et al., "axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199.

Authors:  William B J Cafferty; Ji-Eun Kim; Jung-Kil Lee; Stephen M Strittmatter
Journal:  Neuron       Date:  2007-04-19       Impact factor: 17.173

4.  PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration.

Authors:  Rajeev Sivasankaran; Jiong Pei; Kevin C Wang; Yi Ping Zhang; Christopher B Shields; Xiao-Ming Xu; Zhigang He
Journal:  Nat Neurosci       Date:  2004-02-08       Impact factor: 24.884

5.  Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.

Authors:  Shuxin Li; Ji-Eun Kim; Stephane Budel; Thomas G Hampton; Stephen M Strittmatter
Journal:  Mol Cell Neurosci       Date:  2005-05       Impact factor: 4.314

6.  Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.

Authors:  Ji-Eun Kim; Betty P Liu; James H Park; Stephen M Strittmatter
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

Review 7.  License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins.

Authors:  Shoshanna Vaynman; Fernando Gomez-Pinilla
Journal:  Neurorehabil Neural Repair       Date:  2005-12       Impact factor: 3.919

8.  Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.

Authors:  Marco Domeniconi; Zixuan Cao; Timothy Spencer; Rajeev Sivasankaran; Kevin Wang; Elena Nikulina; Noriko Kimura; Hong Cai; Kangwen Deng; Ying Gao; Zhigang He; Marie Filbin
Journal:  Neuron       Date:  2002-07-18       Impact factor: 17.173

9.  Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.

Authors:  Shuxin Li; Betty P Liu; Stephane Budel; Mingwei Li; Benxiu Ji; Lee Walus; Weiwei Li; Adrienna Jirik; Sylvia Rabacchi; Eugene Choi; Dane Worley; Dinah W Y Sah; Blake Pepinsky; Daniel Lee; Jane Relton; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

10.  The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho.

Authors:  Toshihide Yamashita; Haruhisa Higuchi; Masaya Tohyama
Journal:  J Cell Biol       Date:  2002-05-13       Impact factor: 10.539

View more
  47 in total

1.  Topographically specific regeneration of sensory axons in the spinal cord.

Authors:  Pamela Harvey; Bangjian Gong; Anthony J Rossomando; Eric Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

2.  Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism.

Authors:  Niraj R Mehta; Thien Nguyen; John W Bullen; John W Griffin; Ronald L Schnaar
Journal:  ACS Chem Neurosci       Date:  2010-03-17       Impact factor: 4.418

3.  LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition.

Authors:  Rhalena Thomas; Kristy Favell; Jose Morante-Redolat; Madeline Pool; Christopher Kent; Melissa Wright; Kathleen Daignault; Gino B Ferraro; Samuel Montcalm; Yves Durocher; Alyson Fournier; Jordi Perez-Tur; Philip A Barker
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

5.  Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth.

Authors:  Stéphane Budel; Thihan Padukkavidana; Betty P Liu; Zeny Feng; Fenghua Hu; Sam Johnson; Juha Lauren; James H Park; Aaron W McGee; Ji Liao; Althea Stillman; Ji-Eun Kim; Bao-Zhu Yang; Stefano Sodi; Joel Gelernter; Hongyu Zhao; Fuki Hisama; Amy F T Arnsten; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

6.  The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.

Authors:  Jason Hatakeyama; Jessica H Wald; Hanine Rafidi; Antonio Cuevas; Colleen Sweeney; Kermit L Carraway
Journal:  Sci Signal       Date:  2016-06-28       Impact factor: 8.192

Review 7.  Central nervous system regeneration inhibitors and their intracellular substrates.

Authors:  Michelle Nash; Horia Pribiag; Alyson E Fournier; Christian Jacobson
Journal:  Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.590

8.  Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules.

Authors:  Eun-Mi Hur; In Hong Yang; Deok-Ho Kim; Justin Byun; Wen-Lin Xu; Philip R Nicovich; Raymond Cheong; Andre Levchenko; Nitish Thakor; Feng-Quan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

Review 9.  Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.

Authors:  Roman J Giger; Karthik Venkatesh; Onanong Chivatakarn; Stephen J Raiker; Laurie Robak; Thomas Hofer; Hakjoo Lee; Christoph Rader
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

10.  The Brain-Specific Neural Zinc Finger Transcription Factor 2b (NZF-2b/7ZFMyt1) Suppresses Cocaine Self-Administration in Rats.

Authors:  Vijay Chandrasekar; Jean-Luc Dreyer
Journal:  Front Behav Neurosci       Date:  2010-04-05       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.